$CJMB

CALLAN JMB INC.

CIK:0002032545|SEC Filings

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Income Statement [Abstract]
Revenue	$ 1,376,326	$ 1,666,309	$ 2,482,468	$ 3,115,687
Cost of revenue	618,380	1,022,439	1,297,288	1,858,724
Gross profit	757,946	643,870	1,185,180	1,256,963
Selling, general and administrative expenses	2,104,592	2,050,410	4,233,015	3,901,878
Loss from operations	(1,346,646)	(1,406,540)	(3,047,835)	(2,644,915)
Other income (expenses)
Interest income	1,137	2,042	3,030	4,251
Interest expense	(2,421)		(2,421)	(63)
Other expenses	(150,000)		(150,000)
Other income	150,000		150,000
ELOC facility transaction expenses			(1,177,223)
Changes in fair value of derivative liability	120,841		(217,388)
Total other income (expenses)	119,557	2,042	(1,394,002)	4,188
Loss before income taxes	(1,227,089)	(1,404,498)	(4,441,837)	(2,640,727)
Provision (benefit) for income taxes	4,834	(3,102)	5,140	1,259
Net loss	$ (1,231,923)	$ (1,401,396)	$ (4,446,977)	$ (2,641,986)
Weighted average common shares outstanding - basic	5,646,118	4,456,962	5,551,248	4,167,828
Weighted average common shares outstanding - diluted	5,646,118	4,456,962	5,551,248	4,167,828
Net loss per common share - basic	$ (0.22)	$ (0.31)	$ (0.80)	$ (0.63)
Net loss per common share - diluted	$ (0.22)	$ (0.31)	$ (0.80)	$ (0.63)

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended				6 Months Ended		12 Months Ended
	Jun. 30, 2026	Mar. 31, 2026	Jun. 30, 2025	Mar. 31, 2025	Jun. 30, 2026	Jun. 30, 2025	Dec. 31, 2025
Cash flows from operating activities:
Net loss	$ (1,231,923)	$ (3,215,054)	$ (1,401,396)	$ (1,240,590)	$ (4,446,977)	$ (2,641,986)
Adjustment to reconcile net loss to net cash used in operating activities:
Changes in fair value of derivative liability					217,388
Depreciation					74,226	76,401
Provision (recoveries) for credit losses					(37,750)	(7,666)
Other non-cash expenses relating to ELOC Facility					1,092,222
Stock based compensation	314,253		419,102		708,579	749,927
Right of use asset – operating lease					158,315	137,171
Changes in operating assets and liabilities:
Accounts receivable					119,841	16,369
Inventory					44,702	(39,144)
Other current assets					(71,542)	(271,834)
Right of use liabilities – operating lease					116,786	(131,005)
Accounts payable and accrued expenses					(56,571)	71,593
Deferred revenue						(92,079)
Deferred tax liabilities						(6,602)
Corporate taxes payable					4,838	13,885
Net cash used in operating activities					(2,075,943)	(2,124,970)
Cash flows used in investing activity:
Purchase of property and equipment					(69,481)	(447,506)
Net cash used in investing activity					(69,481)	(447,506)
Cash flows from (used in) financing activities:
Related party loans						18,669
Proceeds from IPO and overallotment, net						4,680,013
Advances to affiliate					(50,061)
Deferred offering costs					(75,000)
Proceeds from offering of ELOC shares					1,000,000
Net cash provided by financing activities					874,939	4,698,682
Increase (decrease) in cash and cash equivalents					(1,270,485)	2,126,206
Cash and cash equivalents at beginning of period		$ 2,130,758		$ 2,097,945	2,130,758	2,097,945	$ 2,097,945
Cash and cash equivalents at end of period	$ 860,273		$ 4,224,151		860,273	4,224,151	$ 2,130,758
Supplemental disclosures of cash flow information:
Cash paid for interest					2,421	63
Lease incentives reimbursement					280,115
Supplemental Schedule of Non-Cash Financing and Investing Activities:
Issuance of common stock for ELOC-related consideration and expenses					1,092,222
Right of use assets acquired and operating lease liabilities recognized for new lease arrangement					(38,737)	(708,321)
Right-of-use assets and operating lease liabilities due to lease modifications						(704,927)
Fair value of Stock Warrants issued at IPO						144,358
Deferred offering costs charged to additional paid-in-capital						136,025
Restricted stock unit awards vesting					$ 38	$ 38

Condensed Consolidated Balance Sheets - USD ($)	Jun. 30, 2026	Dec. 31, 2025
Current Assets:
Cash and cash equivalents	$ 860,273	$ 2,130,758
Accounts receivable, net of allowance for credit losses of $23,925 and $61,675, respectively	261,155	343,246
Inventory	198,583	243,285
Deferred offering costs	75,000
Other current assets	412,853	341,311
Total current assets	1,807,864	3,058,600
Right of use assets – operating lease	1,798,340	1,917,563
Advances to affiliate	50,061
Property and equipment, net of accumulated depreciation of $834,881 and $760,655, respectively	794,793	799,538
Total assets	4,451,058	5,775,701
Current Liabilities:
Accounts payable	598,139	564,014
Accrued expenses	411,487	502,183
Corporate taxes payable	27,923	23,085
Right of use liabilities – operating lease	352,143	323,935
Total current liabilities	1,389,692	1,413,217
Right of use liabilities – operating lease	1,790,899	1,663,229
Derivative liability	588,604	371,216
Total long-term liabilities	2,379,503	2,034,445
Total liabilities	3,769,195	3,447,662
Commitments and Contingencies – Note 8
Stockholders’ Equity
Preferred stock - authorized 10,000,000 shares, $0.001 par value; zero issued and outstanding as of June 30, 2026 and December 31, 2025
Common stock - authorized 190,000,000 shares, par value $0.001 par value, 5,664,868 issued and outstanding as of June 30, 2026 and 4,858,663 December 31, 2025	5,665	4,860
Additional Paid in Capital	15,383,189	12,583,193
Accumulated Deficit	(14,706,991)	(10,260,014)
Total Stockholders’ Equity	681,863	2,328,039
Total Liabilities and Stockholders’ Equity	$ 4,451,058	$ 5,775,701